Table 1.
Number | SNP | Nearest gene(s) | Chromosome | Reported p values* |
1 | rs17753641† | IL12A | 3 | 8.11E−10 |
2 | rs17810546† | IL12A | 3 | 1.01E−07 |
3 | rs601338‡ | FUT2 | 19 | 6.51E−09 |
4 | rs1047781‡ | FUT2 | 19 | 6.50E−04 |
5 | rs3783550 | IL1A–IL1B | 2 | 1.29E−08 |
6 | rs913678 | CEBPB–PTPN1 | 20 | 1.10E−09 |
7 | rs7075773§ | ADO-EGR2 | 10 | 1.69E−09 |
8 | rs1509966‡ | ADO-EGR2 | 10 | 1.47E−06 |
9 | rs224127‡ | ADO-EGR2 | 10 | 1.56E−06 |
10 | rs9316059‡ | LACC1 | 13 | 1.16E−05 |
11 | rs10176241 | THADA | 2 | 3.05E−05 |
12 | rs79891766† | LONRF2 | 2 | 3.60E−05 |
13 | rs116379815† | RBM6 | 3 | 4.17E−07 |
14 | rs11248047 | CPLX1 | 4 | 1.27E−07 |
15 | rs13190001† | C5orf56 | 5 | 1.19E−05 |
16 | rs17705333 | INHBA | 7 | 1.82E−05 |
17 | rs9656588 | IKZF1 | 7 | 5.28E−06 |
18 | rs10094579 | RIPK2 | 8 | 6.03E−07 |
19 | rs2230801‡ | RIPK2 | 8 | 9.60E−06 |
20 | rs911603 | TNFSF8 | 9 | 1.17E−05 |
21 | rs28734985 | IPMK-UBE2D1 | 10 | 4.10E−05 |
22 | rs1698386§† | IPMK-UBE2D1 | 10 | 1.36E−05 |
23 | rs10896027 | MAP3K11-RELA | 11 | 2.58E−05 |
24 | rs58950470§ | MAP3K11-RELA | 11 | 6.25E−07 |
25 | rs4906762 | ATP10A | 15 | 3.81E−05 |
26 | rs3844576 | SOCS1-TNP2 | 16 | 3.09E−06 |
27 | rs1793978 | CKM-KLC3 | 19 | 2.70E−05 |
*The association of SNPs reported by the Immunochip study in Turkish patients.
†Some SNPs (six in total) were excluded since they were not polymorphic in Han Chinese (rs17753641, rs17810546, rs79891766, rs116379815, rs13190001 and rs1698386). The SNPrs2647935, with p<5×10−5, was selected as an alternative SNP in IL12A.
‡The SNPs identified by meta-analysis.
§Imputed SNPs that with more significant association than the lead SNPs in loci and that is not in high linkage disequilibrium with lead SNPs in Chinese Han population (r2 <0.8, Han Chinese Beijing).
SNP, single nucleotide polymorphism.